Similar articles

• Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.

  Harrison N, Mitterbauer M, Tobudic S, Kalhs P, Rabitsch W, Greinix H, Burgmann H, Willinger B, Presterl E, Forstner C. Harrison N, et al. BMC Infect Dis. 2015 Dec 29;15:584. doi: 10.1186/s12879-015-1329-6. BMC Infect Dis. 2015. PMID: 26715563 Free PMC article.
• Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.

  Sun Y, Meng F, Han M, Zhang X, Yu L, Huang H, Wu D, Ren H, Wang C, Shen Z, Ji Y, Huang X. Sun Y, et al. Biol Blood Marrow Transplant. 2015 Jun;21(6):1117-26. doi: 10.1016/j.bbmt.2015.03.018. Epub 2015 Mar 31. Biol Blood Marrow Transplant. 2015. PMID: 25840339
• Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation.

  Girmenia C, Ferretti A, Barberi W. Girmenia C, et al. Curr Opin Hematol. 2014 Nov;21(6):459-65. doi: 10.1097/MOH.0000000000000086. Curr Opin Hematol. 2014. PMID: 25295743 Review.
• Antifungal agents in hematopoietic stem cell transplantation.

  Parameswaran GI, Segal BH, Almyroudis NG. Parameswaran GI, et al. Curr Pharm Des. 2008;14(20):2011-21. doi: 10.2174/138161208785061391. Curr Pharm Des. 2008. PMID: 18691111 Review.
• Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.

  Choi JK, Cho SY, Yoon SS, Moon JH, Kim SH, Lee JH, Kim JS, Cheong JW, Jang JH, Seo BJ, Kim YJ, Lee HJ, Lee J, Lee JW, Lee DG. Choi JK, et al. Biol Blood Marrow Transplant. 2017 Oct;23(10):1773-1779. doi: 10.1016/j.bbmt.2017.06.012. Epub 2017 Jun 28. Biol Blood Marrow Transplant. 2017. PMID: 28668492